about
Targeting the epidermal growth factor receptor in solid tumors: focus on safety.The Myocyte-Damaging Effects of the BCR-ABL1-Targeted Tyrosine Kinase Inhibitors Increase with Potency and Decrease with Specificity.Heart failure years after cancer treatment.Nanomolar-Potency Small Molecule Inhibitor of STAT5 Protein.Prevention of fostamatinib-induced blood pressure elevation by antihypertensive agents.[Pharmacotherapy of solid tumors. New hopes and frustrations].
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cardiovascular toxicity of tyrosine kinase inhibitors.
@en
type
label
Cardiovascular toxicity of tyrosine kinase inhibitors.
@en
prefLabel
Cardiovascular toxicity of tyrosine kinase inhibitors.
@en
P2093
P2860
P1476
Cardiovascular toxicity of tyrosine kinase inhibitors.
@en
P2093
Elie Mouhayar
Jean-Bernard Durand
Jorge Cortes
P2860
P304
P356
10.1517/14740338.2013.788642
P407
P577
2013-04-08T00:00:00Z